(BTI) British American Tobacco - Ratings and Ratios

Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US1104481072

Cigarettes, Vapour, Heated, Oral, Snus

EPS (Earnings per Share)

EPS (Earnings per Share) of BTI over the last years for every Quarter: "2020-12": 0.976, "2021-03": 0.9793, "2021-06": 0, "2021-09": 0, "2021-12": 0, "2022-03": 0, "2022-06": 0, "2022-09": 0, "2022-12": 1.28, "2023-03": 0, "2023-06": 0, "2023-09": 2.39, "2023-12": 375.6, "2024-03": 0, "2024-06": 200.3, "2024-09": 0, "2024-12": -0.66, "2025-03": 0, "2025-06": 2.04, "2025-09": 0,

Revenue

Revenue of BTI over the last years for every Quarter: 2020-12: 13505, 2021-03: 6087.5, 2021-06: 6087.5, 2021-09: 6754.5, 2021-12: 6754.5, 2022-03: 6434.5, 2022-06: 6434.5, 2022-09: 7393, 2022-12: 7393, 2023-03: 6720.5, 2023-06: 13441, 2023-09: 6921, 2023-12: 13842, 2024-03: null, 2024-06: 12340, 2024-09: null, 2024-12: 13527, 2025-03: null, 2025-06: 12069, 2025-09: null,

Dividends

Dividend Yield 6.22%
Yield on Cost 5y 11.73%
Yield CAGR 5y 0.10%
Payout Consistency 89.1%
Payout Ratio 2.2%
Risk via 5d forecast
Volatility 20.0%
Value at Risk 5%th 31.3%
Relative Tail Risk -4.92%
Reward TTM
Sharpe Ratio 2.30
Alpha 67.17
CAGR/Max DD 1.27
Character TTM
Hurst Exponent 0.481
Beta 0.073
Beta Downside 0.121
Drawdowns 3y
Max DD 20.65%
Mean DD 7.72%
Median DD 7.26%

Description: BTI British American Tobacco December 02, 2025

British American Tobacco p.l.c. (NYSE: BTI) is a global tobacco and nicotine company that markets a broad portfolio-including combustible cigarettes, vapour, heated-tobacco, and modern oral nicotine products-through well-known brands such as Vuse, glo, Velo, Camel, Dunhill and Lucky Strike. Its distribution network spans the Americas, Europe, Asia-Pacific, the Middle East, Africa and the United States, and the firm is headquartered in London, United Kingdom.

Key recent metrics: FY 2023 net revenue was $27.3 billion, with an adjusted operating margin of 31 %-the highest in the sector, driven largely by a ~15 % share of next-generation products (NGPs) in total sales, which grew ≈ 20 % YoY. The company’s free-cash-flow conversion remains above 70 %, supporting its £2 billion annual dividend. Sector-level drivers include declining smoking prevalence in high-income markets (≈ −2 % p.a.) and tightening regulation, which is accelerating the shift toward higher-margin NGPs and price-elastic premium pricing strategies.

For a deeper, data-rich assessment of BTI’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a quick look.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income: -10.75b TTM > 0 and > 6% of Revenue
FCF/TA: 0.17 > 0.02 and ΔFCF/TA 6.47 > 1.0
NWC/Revenue: -4.10% < 20% (prev -4.31%; Δ 0.22% < -1%)
CFO/TA 0.15 > 3% & CFO 16.29b > Net Income -10.75b
Net Debt (-4.40b) to EBITDA (20.68b): -0.21 < 3
Current Ratio: 0.87 > 1.5 & < 3
Outstanding Shares: last quarter (2.21b) vs 12m ago -1.14% < -2%
Gross Margin: 82.49% > 18% (prev 0.74%; Δ 8176 % > 0.5%)
Asset Turnover: 45.23% > 50% (prev 29.04%; Δ 16.19% > 0%)
Interest Coverage Ratio: 3.79 > 6 (EBITDA TTM 20.68b / Interest Expense TTM 4.30b)

Altman Z'' 2.29

A: -0.02 (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b
B: 0.21 (Retained Earnings 22.99b / Total Assets 110.23b)
C: 0.14 (EBIT TTM 16.31b / Avg Total Assets 114.47b)
D: 0.74 (Book Value of Equity 46.75b / Total Liabilities 63.05b)
Altman-Z'' Score: 2.29 = BBB

Beneish M -3.34

DSRI: 0.61 (Receivables 3.48b/3.79b, Revenue 51.78b/34.48b)
GMI: 0.90 (GM 82.49% / 73.90%)
AQI: 0.99 (AQ_t 0.84 / AQ_t-1 0.84)
SGI: 1.50 (Revenue 51.78b / 34.48b)
TATA: -0.25 (NI -10.75b - CFO 16.29b) / TA 110.23b)
Beneish M-Score: -3.34 = AA

ValueRay F-Score (Strict, 0-100) 82.54

1. Piotroski: 5.50pt
2. FCF Yield: 14.92%
3. FCF Margin: 36.14%
4. Debt/Equity: 0.75
5. Debt/Ebitda: -0.21
6. ROIC - WACC: 21.62%
7. RoE: -20.99%
8. Revenue Trend: 55.30%
9. EPS Trend: 13.29%

What is the price of BTI shares?

As of January 25, 2026, the stock is trading at USD 59.16 with a total of 3,076,586 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +5.10%, over three months by +15.62% and over the past year by +69.84%.

Is BTI a buy, sell or hold?

British American Tobacco has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold BTI.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the BTI price?

Issuer Target Up/Down from current
Wallstreet Target Price 59.5 0.6%
Analysts Target Price 59.5 0.6%
ValueRay Target Price 77.5 31%

BTI Fundamental Data Overview January 19, 2026

Market Cap GBP = 94.48b (126.92b USD * 0.7444 USD.GBP)
P/E Trailing = 31.3011
P/E Forward = 11.9474
P/S = 4.9586
P/B = 2.0154
P/EG = 0.4177
Revenue TTM = 51.78b GBP
EBIT TTM = 16.31b GBP
EBITDA TTM = 20.68b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 125.40b GBP (94.48b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 3.79 (Ebit TTM 16.31b / Interest Expense TTM 4.30b)
EV/FCF = 6.70x (Enterprise Value 125.40b / FCF TTM 18.71b)
FCF Yield = 14.92% (FCF TTM 18.71b / Enterprise Value 125.40b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.14 (Enterprise Value 125.40b / Total Assets 110.23b)
Interest Expense / Debt = 2.16% (Interest Expense 764.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.36b (EBIT 16.31b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.68b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.39% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.63% (EBIT 16.31b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.60% (NOPAT 13.36b / Invested Capital 50.21b)
WACC = 4.98% (E(94.48b)/V(129.80b) * Re(6.18%) + D(35.33b)/V(129.80b) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.57%
[DCF Debug] Terminal Value 87.27% ; FCFF base≈16.22b ; Y1≈17.92b ; Y5≈23.17b
Fair Price DCF = 316.9 (EV 683.71b - Net Debt -4.40b = Equity 688.12b / Shares 2.17b; r=5.90% [WACC]; 5y FCF grow 12.09% → 2.90% )
EPS Correlation: 13.29 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 55.30 | Revenue CAGR: -2.95% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=4.87 | Chg30d=+0.079 | Revisions Net=-2 | Growth EPS=+5.7% | Growth Revenue=+2.9%

Additional Sources for BTI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle